301 related articles for article (PubMed ID: 26626718)
1. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
Strukova EN; Portnoy YA; Zinner SH; Firsov AA
J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
[TBL] [Abstract][Full Text] [Related]
2. Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models.
Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH; Firsov AA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1208-15. PubMed ID: 26643328
[TBL] [Abstract][Full Text] [Related]
3. Bacterial antibiotic resistance studies using in vitro dynamic models: Population analysis vs. susceptibility testing as endpoints of mutant enrichment.
Firsov AA; Strukova EN; Portnoy YA; Shlykova DS; Zinner SH
Int J Antimicrob Agents; 2015 Sep; 46(3):313-8. PubMed ID: 26297633
[TBL] [Abstract][Full Text] [Related]
4. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
Firsov AA; Smirnova MV; Strukova EN; Vostrov SN; Portnoy YA; Zinner SH
Int J Antimicrob Agents; 2008 Dec; 32(6):488-93. PubMed ID: 18790614
[TBL] [Abstract][Full Text] [Related]
5. Bacterial resistance studies using in vitro dynamic models: the predictive power of the mutant prevention and minimum inhibitory antibiotic concentrations.
Firsov AA; Strukova EN; Shlykova DS; Portnoy YA; Kozyreva VK; Edelstein MV; Dovzhenko SA; Kobrin MB; Zinner SH
Antimicrob Agents Chemother; 2013 Oct; 57(10):4956-62. PubMed ID: 23896481
[TBL] [Abstract][Full Text] [Related]
6. Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model.
Zinner SH; Gilbert D; Greer K; Portnoy YA; Firsov AA
J Antimicrob Chemother; 2013 Apr; 68(4):881-7. PubMed ID: 23175594
[TBL] [Abstract][Full Text] [Related]
7. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
[TBL] [Abstract][Full Text] [Related]
8. Predicting bacterial resistance using the time inside the mutant selection window: possibilities and limitations.
Firsov AA; Portnoy YA; Strukova EN; Shlykova DS; Zinner SH
Int J Antimicrob Agents; 2014 Oct; 44(4):301-5. PubMed ID: 25218155
[TBL] [Abstract][Full Text] [Related]
9. Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid.
Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Zinner SH; Firsov AA
J Antibiot (Tokyo); 2018 May; 71(5):514-521. PubMed ID: 29348530
[TBL] [Abstract][Full Text] [Related]
10. Species differences in ciprofloxacin resistance among Gram-negative bacteria: can "anti-mutant" ratios of the area under the concentration-time curve to the MIC be achieved clinically?
Strukova EN; Portnoy YA; Zinner SH; Firsov AA
J Chemother; 2017 Dec; 29(6):351-357. PubMed ID: 28587559
[TBL] [Abstract][Full Text] [Related]
11. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
Zinner SH; Lubenko IY; Gilbert D; Simmons K; Zhao X; Drlica K; Firsov AA
J Antimicrob Chemother; 2003 Oct; 52(4):616-22. PubMed ID: 12951352
[TBL] [Abstract][Full Text] [Related]
12. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
Firsov AA; Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Romanov AV; Edelstein MV; Zinner SH
J Antimicrob Chemother; 2017 Nov; 72(11):3100-3107. PubMed ID: 28981793
[TBL] [Abstract][Full Text] [Related]
13. In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.
Firsov AA; Golikova MV; Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH
Antimicrob Agents Chemother; 2015 Feb; 59(2):1014-9. PubMed ID: 25451050
[TBL] [Abstract][Full Text] [Related]
14. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.
Hyatt JM; Schentag JJ
Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S9-11. PubMed ID: 10654629
[TBL] [Abstract][Full Text] [Related]
16. [Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa].
Liu MT; Sheng MY; Zhang Y; Li Y
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1427-31. PubMed ID: 21756818
[TBL] [Abstract][Full Text] [Related]
17. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
18. ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.
Firsov AA; Vostrov SN; Lubenko IY; Arzamastsev AP; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2004 Jul; 54(1):178-86. PubMed ID: 15190041
[TBL] [Abstract][Full Text] [Related]
19. Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa.
Rees VE; Bulitta JB; Nation RL; Tsuji BT; Sörgel F; Landersdorfer CB
J Antimicrob Chemother; 2015 Mar; 70(3):818-26. PubMed ID: 25381167
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.
Firsov AA; Lubenko IY; Smirnova MV; Strukova EN; Zinner SH
Antimicrob Agents Chemother; 2008 Jun; 52(6):1924-8. PubMed ID: 18378704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]